Opinion & analysis

Cannabis Industry Taking Legal Action Against EU Regulators Over CBD Novel Food Classification

In response to the recent controversial European Commission decision to classify products containing cannabidiol (CBD) as “novel foods”, the Cannabis Trades Association UK has begun legal action to challenge the classification. Read more about the controversy and legal proceedings here.

Cannabis Industry Taking Legal Action Against EU Regulators Over CBD Novel Food Classification

CAR-T Label Update Could Address Medicare Coverage Challenges, FDA’s Gottlieb Suggests

CBD Suits Challenge ‘THC-Free’ Claims After Users Fail Drug Tests; Plaintiffs Bar May Just Be Warming Up

Cell And Gene Therapies Test New Waters In Pricing And Reimbursement

Cell And Gene Therapy Logistics Requires Early Planning

CEO-To-Worker Pay Ratios Averaged 150-1 At Six Top Medtech Companies In 2017

CMS Actively Looking For New Reimbursement Pathway For Innovative Devices

Colgate/Tom’s Of Maine Pays Back Unilever For ‘Naturally Dry’ Loss

Commission Addresses Non-EU/EEA Authorities To Set Record Straight On New EU Regs

Commission Looks Set To Expand MDR Extension So Notified Bodies Can Focus On High-Risk Devices

Commission Would Back Limited Expansion Of Products Covered By MDR Grace Period

Contamination In Common OTC Antacid Adds To FDA’s API Impurity Concerns

Cosmetic Preservatives Crisis Creeping Into CIR Program

Countdown To Transition: US FDA Says 91 Drugs Will Become Biologics In March 2020

Culture Change At GSK: ‘We’re Doing What We Said We’d Do’